Artificial Disc Implants for Cervical Spine Conditions

Comparison of Artificial Disc Implants in Cervical Disc Arthroplasty

Recruiting Observational Study
Cervical Spondylosis With Myelopathy Cervical Radiculopathy Cervical Disc Herniation Degenerative Disc Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Observational
Participants needed
20 (estimated)
Sponsor
University of California, Los Angeles · Other
Who this trial is looking for

This trial is looking for adults aged 18 to 60 who have specific neck problems caused by disc issues and haven’t improved with non-surgical treatments. Participants will receive one of two types of artificial discs and will be monitored over one and a half years.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 18 and 60 years old.
  • I have cervical spondylotic myelopathy and/or radiculopathy.
  • I have not improved after at least six weeks of conservative care.
  • I plan to have cervical arthroplasty for my condition.
  • I have signed the informed consent form.

You may not be able to join if

  • I have had prior cervical spine surgery.
  • I have more than two diseased levels that need surgery.
  • I am allergic to metal or polyethylene.
  • I am morbidly obese.
  • I have an active local or systemic infection.
  • I have conditions that affect my ability to give consent or participate.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study will comprehensively evaluate the outcomes and endpoints of these two different FDA-approved artificial disc implants used to treat cervical spondylotic myelopathy and/or radiculopathy today: Biomet Zimmer Mobi-C and Nuvasive Simplify. Both implants are structurally different with the Nuvasive Simplify implementing a three-piece design with two endplates and a semi-constrained mobile co…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient is skeletally mature and between 18 to 60 years of age * Experiences cervical spondylotic myelopathy and/or radiculopathy typically caused by disc herniation or degenerative disc disease at a single level between C3 to C7 * Is unresponsive to at least six weeks of non-…
Contacts

Daniel C Lu, MD, PhD

(310) 267-2975

dclu@mednet.ucla.edu

CONTACT

Sandra Holley, PhD

310-267-1770

sholley@mednet.ucla.edu

CONTACT